ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DDSS Labopharm Inc. (MM)

0.14
0.00 (0.00%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Labopharm Inc. (MM) NASDAQ:DDSS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.14 0 01:00:00

Labopharm to host conference call Thursday, August 4, 2011 at 8:30 A.M. (ET)

28/07/2011 12:00pm

PR Newswire (Canada)


Labopharm Inc. (MM) (NASDAQ:DDSS)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Labopharm Inc. (MM) Charts.
LAVAL, QC, July 28, 2011 /CNW/ -- - Management to discuss second quarter 2011 financial results - LAVAL, QC, July 28, 2011 /CNW/ - Labopharm Inc. (TSX: DDS) (NASDAQ: DDSS) today announced that it will host a conference call on Thursday, August 4, 2011 at 8:30 a.m. (ET) to discuss its second quarter 2011 financial results. Labopharm will report its second quarter 2011 financial results via news release at approximately 7:00 a.m. (ET) the same day. To access the conference call by telephone, dial 647-427-7450 or 1-888-231-8191.  Please connect approximately 15 minutes prior to the beginning of the call to ensure participation.  The conference call will be archived for replay until Thursday, August 11, 2011 at midnight.  To access the archived conference call, dial 416-849-0833 or 1-855-859-2056 and enter the reservation number 87032649. A live audio webcast of the conference call will be available at www.labopharm.com. Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast.  The webcast will be archived at the above web site for 30 days. About Labopharm Inc. Labopharm is focused on realizing value from its commercialized products and creating additional value by leveraging its emerging technology platforms to develop increasingly differentiated products. For more information, visit http://www.labopharm.com. To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/July2011/28/c7965.html p buAt The Equicom Group/u/bbr/ Lawrence Chamberlainbr/ Media and Investor Relationsbr/ Tel:  (416) 815-0700 ext. 257br/ a href="mailto:lchamberlain@equicomgroup.com"lchamberlain@equicomgroup.com /abr/ br/ French:br/ Joe Racanellibr/ Tel:  (514) 844-7997br/ a href="mailto:jracanelli@equicomgroup.com"jracanelli@equicomgroup.com/a /p

Copyright

1 Year Labopharm Inc. (MM) Chart

1 Year Labopharm Inc. (MM) Chart

1 Month Labopharm Inc. (MM) Chart

1 Month Labopharm Inc. (MM) Chart